Hydromorphone Hydrochloride 13811-0702
Product NDC
13811-0702- Manufacturer
- Trigen Laboratories, Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- September 15, 2016
- Listing Expires
- December 31, 2026
- Application
- ANDA205629
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 12 mg/1 |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(1)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-702-10)